Michael Gahlert

Osseointegration of zirconia and titanium dental implants: a histological and histomorphometrical study in the maxilla of pigs

OBJECTIVES The purpose of the present study was to histologically compare the bone tissue responses to surface-modified zirconia and titanium implants. METHODS Threaded zirconia implants were produced using a new low-pressure injection moulding technique and thereafter surface treated by acid etching. Titanium implants with the exact shape and surface treated by sandblasting and acid etching (SLA) served as controls. Fifteen adult pigs received both implant types in the maxilla 6 months after extraction of the second and third incisors. The animals were sacrificed after 4, 8 and 12 weeks and 30 implants with surrounding bone were retrieved. RESULTS Histological evaluation showed osseous integration for both materials. Zirconia implants revealed mean peri-implant bone density values of 42.3% (SD +/- 14.5) at 4 weeks, 52.6% (SD +/- 5.7) at 8 weeks and 54.6% (SD +/- 11.5) at 12 weeks after implantation, whereas Ti-SLA implants demonstrated mean values of 29% (SD +/- 10), 44.1% (SD +/- 18) and 51.6% (SD +/- 8.6) at corresponding time intervals. With respect to the bone-implant contact ratio, the mean values for zirconia ranged between 27.1% (SD +/- 3.5) and 51.1% (SD +/- 12.4) and for Ti-SLA, it ranged between 23.5% (SD +/- 7.5) and 58.5% (SD +/- 11.4). For the parameters investigated, no statistically significant differences between both types of implants could be detected at any time point. CONCLUSIONS No statistical difference between implants could be demonstrated with any of the methods used. The limited number of animals per group, however, does not allow to conclude that there is no difference in osseointegration between the two types of implants, although the data tend to suggest such a trend.

A comparison study of the osseointegration of zirconia and titanium dental implants. A biomechanical evaluation in the maxilla of pigs.

OBJECTIVES The purpose of the present study was to investigate the osseointegration of microstructured zirconia implants in comparison with sandblasted and acid-etched (SLA) titanium implants in a biomechanical study. MATERIALS Zirconia implants (4.1 mm in diameter, 10 mm in length) were produced using a new low pressure injection molding technique. After that the implants were acid-etched with hydrofluoric acid. Standard Ti-SLA implants of the exact same shape served as controls. Six months after extraction of incisors 2 and 3, 16 adult pigs received a total of 64 implants in the maxillae. After 4, 8, and 12 weeks the animals were sacrificed, and 59 implants could be analyzed to removal torque (RTQ) testing. RESULTS The mean RTQ values for zirconia implants were 42.4 Ncm at 4 weeks, 69.6 Ncm at 8 weeks, and 69.3 Ncm at 12 weeks of healing, whereas RTQ values for the Ti-SLA implants were 42.1 Ncm, 75.0 Ncm, and 73.1 Ncm at corresponding time intervals. There is no statistical difference in RTQ values between Ti-SLA and zirconia implants at 8 weeks. CONCLUSIONS Within the limits of the present study it was concluded that acid-etching of zirconia implants enhances bone apposition resulting in RTQ values which were equivalent to that of Ti-SLA.

Failure analysis of fractured dental zirconia implants

OBJECTIVES The purpose of the present study was the macroscopic and microscopic failure analysis of fractured zirconia dental implants. METHODS Thirteen fractured one-piece zirconia implants (Z-Look3) out of 170 inserted implants with an average in situ period of 36.75±5.34 months (range from 20 to 56 months, median 38 months) were prepared for macroscopic and microscopic (scanning electron microscopy [SEM]) failure analysis. These 170 implants were inserted in 79 patients. The patient histories were compared with fracture incidences to identify the reasons for the failure of the implants. RESULTS Twelve of these fractured implants had a diameter of 3.25 mm and one implant had a diameter of 4 mm. All fractured implants were located in the anterior side of the maxilla and mandibula. The patient with the fracture of the 4 mm diameter implant was adversely affected by strong bruxism. By failure analysis (SEM), it could be demonstrated that in all cases, mechanical overloading caused the fracture of the implants. Inhomogeneities and internal defects of the ceramic material could be excluded, but notches and scratches due to sandblasting of the surface led to local stress concentrations that led to the mentioned mechanical overloading by bending loads. CONCLUSIONS The present study identified a fracture rate of nearly 10% within a follow-up period of 36.75 months after prosthetic loading. Ninety-two per cent of the fractured implants were so-called diameter reduced implants (diameter 3.25 mm). These diameter reduced implants cannot be recommended for further clinical use. Improvement of the ceramic material and modification of the implant geometry has to be carried out to reduce the failure rate of small-sized ceramic implants. Nevertheless, due to the lack of appropriate laboratory testing, only clinical studies will demonstrate clearly whether and how far the failure rate can be reduced.

Submerged and transmucosal healing yield the same clinical outcomes with two‐piece implants in the anterior maxilla and mandible: interim 1‐year results of a randomized, controlled clinical trial

OBJECTIVES To test whether or not transmucosal healing at two-piece implants is as successful as submerged placement regarding crestal bone levels and patient satisfaction. MATERIAL AND METHODS Adults requiring implants in the anterior maxilla or mandible in regions 21-25, 11-15, 31-35 or 41-45 (WHO) were recruited for this randomized, controlled multi-center clinical trial of a 5-year duration. Randomization was performed at implantation allowing for either submerged or transmucosal healing. Final reconstructions were seated 6 months after implantation. Radiographic interproximal crestal bone levels and peri-implant soft tissue parameters were measured at implant placement (IP) (baseline), 6 and 12 months. Patient satisfaction was assessed by a questionnaire. A two-sided t-test (80% power, significance level α=0.05) was performed on bone-level changes at 6 and 12 months. RESULTS One hundred and twenty-seven subjects were included in the 12-month analysis (submerged [S]: 52.5%, transmucosal [TM]: 47.2%). From IP to 6 months, the change in the crestal bone level was -0.32 mm (P<0.001) for the S group and -0.29 mm (P<0.001) for the TM group. From IP to 12 months, bone-level changes were statistically significant in both groups (S -0.47 mm, P<0.001; TM -0.48 mm, P<0.001). The mean differences of change in the bone levels between the two groups were not statistically significant at either time point, indicating the equivalence of both procedures. For both groups, very good results were obtained for soft tissue parameters and for patient satisfaction. CONCLUSIONS Transmucosal healing of two-piece implants is as successful as the submerged healing mode with respect to tissue integration and patient satisfaction within the first 12 months after IP.

In Vitro Biofilm Formation on Titanium and Zirconia Implant Surfaces

BACKGROUND It has been hypothesized that zirconia might have a reduced bacterial adhesion compared with titanium; however, results from experimental studies are rather controversial. The aim of the present study is to compare biofilm formation on zirconia and titanium implant surfaces using an in vitro three-species biofilm and human plaque samples. METHODS Experimental disks made of titanium (Ti) or zirconia (ZrO2) with a machined (M) or a sandblasted (SLA) and acid-etched (ZLA) surface topography were produced. An in vitro three-species biofilm or human plaque samples were applied for bacterial adhesion to each type of disk, which after 72 hours of incubation was assessed using an anaerobic flow chamber model. RESULTS Zirconia showed a statistically significant reduction in three-species biofilm thickness compared with titanium (ZrO2-M: 8.41 μm; ZrO2-ZLA: 17.47 μm; Ti-M: 13.12 μm; Ti-SLA: 21.97 μm); however, no differences were found regarding three-species-biofilm mass and metabolism. Human plaque analysis showed optical density values of 0.06 and 0.08 for ZrO2-M and ZrO2-ZLA, and values of 0.1 and 0.13 for Ti-M and Ti-SLA, respectively; indicating a statistically significant reduction in human biofilm mass on zirconia compared with titanium. Additionally, zirconia revealed a statistically significant reduction in human plaque thickness (ZrO2-M: 9.04 μm; ZrO2-ZLA: 13.83 μm; Ti-M: 13.42 μm; Ti-SLA: 21.3 μm) but a similar human plaque metabolism compared with titanium. CONCLUSION Zirconia implant surfaces showed a statistically significant reduction in human plaque biofilm formation after 72 hours of incubation in an experimental anaerobic flow chamber model compared with titanium implant surfaces.

Dental zirconia implants up to three years in function: a retrospective clinical study and evaluation of prosthetic restorations and failures.

PURPOSE The clinical evaluation of one-piece zirconia dental implants with different diameters to determine survival rate and type of implant failure. MATERIALS AND METHODS Information concerning implant surgery (number, diameter, length, and position of inserted implants; patient age, sex, risk factors, and bone quality) was extracted from the clinical records. All treated patients were then recalled for a follow-up examination to check the current clinical parameters concerning soft tissue, implants, and prosthetic reconstructions. RESULTS A total of 79 patients received 170 implants (diameter-reduced 3.25 mm: n = 59; diameter 4.0 mm: n = 82; diameter 5.0 mm: n = 29). The clinical examination showed no signs of gingival inflammation. Prosthetic information was available for 119 implants restored with single crowns (87 implants), fixed partial dentures (25 implants), and removable hybrid dentures (7 implants). Overall, 30 implants were lost due to lack of osseointegration (n = 17) or fracture (n = 13). The diameter-reduced implants showed the lowest survival rate (59.5%) compared to the implants with a diameter of 4.0 mm (90.6%) and 5.0 mm (73.9%). The survival rate for diameters of 3.25 mm was significantly lower than that for diameters of 4.0 mm. The estimated cumulative survival rate up to 3 years demonstrated a survival probability of 82.4% for all types of implant diameters and failure. CONCLUSIONS Based on these results, diameter-reduced zirconia dental implants cannot be recommended for clinical use. The overall survival rate of 82.4% is not acceptable in comparison to the well-established survival rate of titanium implants.

Biomechanical evaluation of a microstructured zirconia implant by a removal torque comparison with a standard Ti‐SLA implant

OBJECTIVES The purpose of this study was to evaluate the biomechanical bone tissue response to novel microstructured zirconia implants in comparison to sandblasted and acid-etched (SLA) titanium implants through the analysis of removal torque (RTQ) measurements. MATERIALS AND METHODS Ti-SLA implants with a sandblasted, large-grit and acid-etched surface were compared with zirconia implants with an acid-etched surface. All implants had the same shape, a diameter of 4.1 mm and a length of 10 mm. A total of 136 implants were placed in the maxillae of 17 miniature pigs. Six animals were sacrificed after both 4 and 8 weeks and five animals were sacrificed after 12 weeks, thus providing a total of 102 implants for RTQ testing (34 implants were reserved for future histological analysis). The RTQ analysis was successfully performed, using a mixed model regression with P-values calculated using the nonparametric Brunner-Langer method, on 100 of the 102 implants, two were excluded from the analysis. RESULTS The adjusted mean RTQ values for Ti-SLA implants were 131 Ncm (95% CI: 107-155) at 4 weeks, 128 Ncm (108-148) Ncm at 8 weeks, and 180 Ncm (153-207 Ncm) at 12 weeks of healing, whereas RTQ values for the zirconia implants were 110 Ncm (86-134), 97 Ncm (76-118) and 147 Ncm (121-174) at the corresponding time intervals. A comparison of the implant materials resulted in P-values of P = 0.114 at 4 weeks, P = 0.034 at 8 weeks and P = 0.105 at 12 weeks (significance set at P < 0.05). CONCLUSIONS Within the limits of the present study, it could be confirmed that the biomechanical bone-tissue response of the investigated zirconia implants is non-inferior to that of the well-documented, roughened titanium surface, at each time point, within the set tolerance. There were no statistically significant differences between the two materials after a healing period of 4 and 12 weeks. The RTQ values of both implant types increased significantly from the 8-week to the 12-week time point.

A Retrospective Clinical Study with Regard to Survival and Success Rates of Zirconia Implants up to and after 7 Years of Loading

PURPOSE The study aims to retrospectively investigate the clinical performance of first-generation zirconia implants with a sandblasted surface up to and after 7 years of loading. MATERIALS AND METHODS Clinical records of patients treated with zirconia implants between 2004 and 2009 were screened. Consequently, adequate patients were invited to a clinical and radiographic investigation to classify each implant according to strict success criteria. RESULTS Seventy-one patients receiving 161 implants were available for the evaluation. Overall, 36 implants (22.4%) were lost due to early (n = 14) and late failures (n = 4) or fractures (n = 18). All surviving 125 implants fulfilled the success criteria. None of the investigated implants had a history of peri-implant infections. Mean values with regard to gingival index, plaque index, modified sulcus bleeding index, and probing depth were 0.03, 0.23, 0.59, and 2.80 mm, respectively. The radiographically evaluated mean crestal bone loss was 0.97 ± 0.07 mm. Diameter-reduced implants (3.25 mm) showed lower survival (58.5%) compared with implants with a diameter of 4.0 mm (88.9%) and 5.0 mm (78.6%). The overall longitudinal survival rate was 77.3%. CONCLUSIONS First-generation zirconia implants showed low overall survival and success rates. The evaluated clinical and radiographic parameters were consistent with healthy peri-implant tissues. Additionally, nonfractured failures were not associated with peri-implant infections.

Clinical and Radiologic Outcomes after Submerged and Transmucosal Implant Placement with Two‐Piece Implants in the Anterior Maxilla and Mandible: 3‐Year Results of a Randomized Controlled Clinical Trial

PURPOSE The aim of this investigation was to evaluate the 3-year outcomes regarding crestal bone level, clinical parameters, and patient satisfaction, following submerged and transmucosal implant placement for two-piece implants in the anterior maxilla and mandible. MATERIALS AND METHODS Patients requiring dental implants for single-tooth replacement in the anterior maxilla or mandible were enrolled in a randomized, controlled, multicenter clinical trial. The implants were randomized at placement to either submerged or transmucosal healing, with final restorations placed after 6 months. Radiographic and clinical parameters were recorded after 1, 2, and 3 years; a questionnaire was also used to assess patient satisfaction. A two-sided, unpaired T-test (significance level p ≤ .05) was used to statistically evaluate the differences between the two groups. RESULTS A total of 106 patients were included in the 3-year analysis. The mean change in crestal bone level from implant placement to 3 years was 0.68 ± 0.98 mm (p < .001) and 0.58 ± 0.77 mm (p < .001) in the submerged and transmucosal groups, respectively; the differences between the groups were not significant. Clinical parameters remained stable throughout the study, with no significant differences between the groups, and patient satisfaction was good or excellent for over 90% of subjects in both groups. CONCLUSIONS The results demonstrate excellent clinical and radiographic conditions after 3 years for implants supporting single-tooth restorations, regardless of whether a submerged or transmucosal surgical technique was used.

Evaluation of Hard and Soft Tissue Dimensions Around Zirconium Oxide Implant-Supported Crowns: A 1-Year Retrospective Study.

BACKGROUND This study aims to evaluate the effect of the distance between the alveolar crest of a full-ceramic implant to the lowest point of the contact area of the crowns on the interdental papilla. Therefore, the authors proposed a new concept of linear measurements for the reproducible and metric evaluation of distances relevant for the assessment of hard and soft tissue changes around dental implants. METHODS A total of 216 sites were examined in 87 patients. In a radiographic and clinical evaluation, four relevant distances were evaluated. In the x-ray image, the tip of the papilla was marked with a radiodense mixture of tungsten powder and temporary cement. In a clinical photograph, the lowest point of the interdental contact zone of the crowns was visualized by a metallic interdental ligature. RESULTS Using the proposed measuring methodology, four different papilla-deficit situations around ceramic implants could be reproducibly distinguished. When the measurement from the bone crest at the implant was ≤5 mm, the papilla was completely present in 100% of cases. When this distance was 10 mm, the papilla was still present in 67% of the cases, without any cosmetically apparent deficit. CONCLUSIONS A close relationship is observed between the distance from the contact point to the bone and the presence of the papilla. Using a combination of radiographically and clinically visible landmarks allows the reproducible measurement of these distances.